Sun Pharmaceutical Industries Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 121,568.6 million compared to INR 111,001.4 million a year ago. Revenue was INR 126,309 million compared to INR 114,148.5 million a year ago. Net income was INR 25,237.5 million compared to INR 21,660.1 million a year ago. Basic earnings per share from continuing operations was INR 10.5 compared to INR 9 a year ago. Diluted earnings per share from continuing operations was INR 10.5 compared to INR 9 a year ago.
For the nine months, sales was INR 359,451.2 million compared to INR 325,533 million a year ago. Revenue was INR 372,622 million compared to INR 332,162.5 million a year ago. Net income was INR 69,218 million compared to INR 64,891.1 million a year ago. Basic earnings per share from continuing operations was INR 28.8 compared to INR 27 a year ago. Diluted earnings per share from continuing operations was INR 28.8 compared to INR 27 a year ago.